318 related articles for article (PubMed ID: 35023054)
1. Neuropathological Mechanisms of β-N-Methylamino-L-Alanine (BMAA) with a Focus on Iron Overload and Ferroptosis.
Kazemi Shariat Panahi H; Dehhaghi M; Heng B; Lane DJR; Bush AI; Guillemin GJ; Tan VX
Neurotox Res; 2022 Apr; 40(2):614-635. PubMed ID: 35023054
[TBL] [Abstract][Full Text] [Related]
2. The Cyanotoxin and Non-protein Amino Acid β-Methylamino-L-Alanine (L-BMAA) in the Food Chain: Incorporation into Proteins and Its Impact on Human Health.
Dunlop RA; Guillemin GJ
Neurotox Res; 2019 Oct; 36(3):602-611. PubMed ID: 31377995
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
Papapetropoulos S
Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
[TBL] [Abstract][Full Text] [Related]
4. Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis.
Ra D; Sa B; Sl B; Js M; Sj M; DA D; Ew S; O K; Eb B; Ad C; Vx T; Gg G; Pa C; Dc M; Wg B
Neurotox Res; 2021 Feb; 39(1):81-106. PubMed ID: 33547590
[TBL] [Abstract][Full Text] [Related]
5. Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease?
Metcalf JS; Codd GA
Amyotroph Lateral Scler; 2009; 10 Suppl 2():74-8. PubMed ID: 19929737
[TBL] [Abstract][Full Text] [Related]
6. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam.
Murch SJ; Cox PA; Banack SA
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12228-31. PubMed ID: 15295100
[TBL] [Abstract][Full Text] [Related]
7. Environmental neurotoxins β-N-methylamino-l-alanine (BMAA) and mercury in shark cartilage dietary supplements.
Mondo K; Broc Glover W; Murch SJ; Liu G; Cai Y; Davis DA; Mash DC
Food Chem Toxicol; 2014 Aug; 70():26-32. PubMed ID: 24755394
[TBL] [Abstract][Full Text] [Related]
8. Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida.
Banack SA; Metcalf JS; Bradley WG; Cox PA
Toxicon; 2014 Nov; 90():167-73. PubMed ID: 25123936
[TBL] [Abstract][Full Text] [Related]
9. Cyanobacterial Neurotoxins: Their Occurrence and Mechanisms of Toxicity.
Rodgers KJ; Main BJ; Samardzic K
Neurotox Res; 2018 Jan; 33(1):168-177. PubMed ID: 28585115
[TBL] [Abstract][Full Text] [Related]
10. Non-Proteinogenic Amino Acid β-N-Methylamino-L-Alanine (BMAA): Bioactivity and Ecological Significance.
Koksharova OA; Safronova NA
Toxins (Basel); 2022 Aug; 14(8):. PubMed ID: 36006201
[TBL] [Abstract][Full Text] [Related]
11. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Bradley WG; Mash DC
Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
[TBL] [Abstract][Full Text] [Related]
12. β-N-Methylamino-L-alanine (BMAA) uptake by the aquatic macrophyte Ceratophyllum demersum.
Esterhuizen M; Pflugmacher S; Downing TG
Ecotoxicol Environ Saf; 2011 Jan; 74(1):74-7. PubMed ID: 20447690
[TBL] [Abstract][Full Text] [Related]
13. Presence of ß-N-methylamino-L-alanine in cyanobacteria and aquatic organisms from waters of Northern Poland; BMAA toxicity studies.
Błaszczyk A; Siedlecka-Kroplewska K; Woźniak M; Mazur-Marzec H
Toxicon; 2021 Apr; 194():90-97. PubMed ID: 33610631
[TBL] [Abstract][Full Text] [Related]
14. Detection of the suspected neurotoxin β-methylamino-l-alanine (BMAA) in cyanobacterial blooms from multiple water bodies in Eastern Australia.
Main BJ; Bowling LC; Padula MP; Bishop DP; Mitrovic SM; Guillemin GJ; Rodgers KJ
Harmful Algae; 2018 Apr; 74():10-18. PubMed ID: 29724339
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and transfer of a cyanobacterial neurotoxin β-methylamino-L-alanine within the aquatic food webs of Gonghu Bay (Lake Taihu, China) to evaluate the potential human health risk.
Jiao Y; Chen Q; Chen X; Wang X; Liao X; Jiang L; Wu J; Yang L
Sci Total Environ; 2014 Jan; 468-469():457-63. PubMed ID: 24055662
[TBL] [Abstract][Full Text] [Related]
16. How does the neurotoxin β-N-methylamino-L-alanine exist in biological matrices and cause toxicity?
Li M; Qiu J; Yan G; Zheng X; Li A
Sci Total Environ; 2024 Apr; 922():171255. PubMed ID: 38417517
[TBL] [Abstract][Full Text] [Related]
17. N-β-Methylamino-L-Alanine and Its Naturally Occurring Isomers in Cyanobacterial Blooms in Lake Winnipeg.
Bishop SL; Kerkovius JK; Menard F; Murch SJ
Neurotox Res; 2018 Jan; 33(1):133-142. PubMed ID: 28965245
[TBL] [Abstract][Full Text] [Related]
18. Uptake of β-N-methylamino-L-alanine (BMAA) into glutamate-specific synaptic vesicles: Exploring the validity of the excitotoxicity mechanism of BMAA.
van Onselen R; Downing TG
Neurosci Lett; 2024 Jan; 821():137593. PubMed ID: 38103629
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of β-methylamino-L-alanine (BMAA) and its isomers in freshwater cyanobacteria isolated from eastern Australia.
Violi JP; Mitrovic SM; Colville A; Main BJ; Rodgers KJ
Ecotoxicol Environ Saf; 2019 May; 172():72-81. PubMed ID: 30682636
[TBL] [Abstract][Full Text] [Related]
20. Bacteria do not incorporate β-N-methylamino-L-alanine into their proteins.
van Onselen R; Cook NA; Phelan RR; Downing TG
Toxicon; 2015 Aug; 102():55-61. PubMed ID: 26051985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
